FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1967639975> ?p ?o ?g. }

• W1967639975 endingPage "3419" @default.
• W1967639975 startingPage "3412" @default.
• W1967639975 abstract "Abstract Purpose: AZD2014 is a novel, oral, m-TORC 1/2 inhibitor that has shown in vitro and in vivo efficacy across a range of preclinical human cancer models. Experimental Design: A rolling six-dose escalation was performed to define an MTD (part A), and at MTD a further cohort of patients was treated to further characterize toxicities and perform pre- and posttreatment biopsies (part B). AZD2014 was administered orally twice a day continuously. Flow cytometry, ELISA, and immunohistochemistry were used to quantify pharmacodynamic biomarkers. Pharmacokinetic analysis was carried out by mass spectrometry. Results: A total of 56 patients were treated across a dose range of 25 to 100 mg. The MTD was 50 mg twice daily. The dose-limiting toxicities were fatigue and mucositis. At the MTD, the most common adverse events (AE) were fatigue (78%), nausea (51%), and mucositis (49%), but these were equal to or greater than grade 3 in only 5% of patients. Drug levels achieved at the MTD (AUCss 6686 ng·h/mL, Cmax ss 1,664 ng/mL) were consistent with activity in preclinical models. A reduction in p-S6 levels and Ki67 staining was observed in 8 of 8 and 5 of 9 evaluable paired biopsy samples. Partial responses were seen in a patient with pancreatic cancer and a patient with breast cancer, who were found to have a PDGFR and ERBB2 mutation, respectively. Conclusions: The recommended phase II dose for further evaluation of AZD2014 is 50 mg twice daily, and at this dose it has been possible to demonstrate pharmacologically relevant plasma concentrations, target inhibition in tumor, and clinical responses. Clin Cancer Res; 21(15); 3412–9. ©2015 AACR." @default.
• W1967639975 created "2016-06-24" @default.
• W1967639975 creator A5016703081 @default.
• W1967639975 creator A5017721654 @default.
• W1967639975 creator A5018478201 @default.
• W1967639975 creator A5028617609 @default.
• W1967639975 creator A5030548564 @default.
• W1967639975 creator A5032401979 @default.
• W1967639975 creator A5037530844 @default.
• W1967639975 creator A5041845055 @default.
• W1967639975 creator A5055792960 @default.
• W1967639975 creator A5069044650 @default.
• W1967639975 creator A5070839902 @default.
• W1967639975 creator A5072378199 @default.
• W1967639975 creator A5075755839 @default.
• W1967639975 creator A5076536596 @default.
• W1967639975 creator A5086964113 @default.
• W1967639975 date "2015-08-01" @default.
• W1967639975 modified "2023-10-16" @default.
• W1967639975 title "First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014" @default.
• W1967639975 cites W1981711832 @default.
• W1967639975 cites W2000731858 @default.
• W1967639975 cites W2028704745 @default.
• W1967639975 cites W2045178199 @default.
• W1967639975 cites W2076670881 @default.
• W1967639975 cites W2080100938 @default.
• W1967639975 cites W2089413248 @default.
• W1967639975 cites W2097881410 @default.
• W1967639975 cites W2113491029 @default.
• W1967639975 cites W2115686439 @default.
• W1967639975 cites W2116622644 @default.
• W1967639975 cites W2118677643 @default.
• W1967639975 cites W2118776368 @default.
• W1967639975 cites W2127783189 @default.
• W1967639975 cites W2129227644 @default.
• W1967639975 cites W2143112776 @default.
• W1967639975 cites W2149218373 @default.
• W1967639975 cites W2150937214 @default.
• W1967639975 cites W2153493705 @default.
• W1967639975 cites W2153867442 @default.
• W1967639975 cites W2154836325 @default.
• W1967639975 cites W2165534057 @default.
• W1967639975 cites W2167188058 @default.
• W1967639975 cites W2260883352 @default.
• W1967639975 doi "https://doi.org/10.1158/1078-0432.ccr-14-2422" @default.
• W1967639975 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4512239" @default.
• W1967639975 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25805799" @default.
• W1967639975 hasPublicationYear "2015" @default.
• W1967639975 type Work @default.
• W1967639975 sameAs 1967639975 @default.
• W1967639975 citedByCount "98" @default.
• W1967639975 countsByYear W19676399752015 @default.
• W1967639975 countsByYear W19676399752016 @default.
• W1967639975 countsByYear W19676399752017 @default.
• W1967639975 countsByYear W19676399752018 @default.
• W1967639975 countsByYear W19676399752019 @default.
• W1967639975 countsByYear W19676399752020 @default.
• W1967639975 countsByYear W19676399752021 @default.
• W1967639975 countsByYear W19676399752022 @default.
• W1967639975 countsByYear W19676399752023 @default.
• W1967639975 crossrefType "journal-article" @default.
• W1967639975 hasAuthorship W1967639975A5016703081 @default.
• W1967639975 hasAuthorship W1967639975A5017721654 @default.
• W1967639975 hasAuthorship W1967639975A5018478201 @default.
• W1967639975 hasAuthorship W1967639975A5028617609 @default.
• W1967639975 hasAuthorship W1967639975A5030548564 @default.
• W1967639975 hasAuthorship W1967639975A5032401979 @default.
• W1967639975 hasAuthorship W1967639975A5037530844 @default.
• W1967639975 hasAuthorship W1967639975A5041845055 @default.
• W1967639975 hasAuthorship W1967639975A5055792960 @default.
• W1967639975 hasAuthorship W1967639975A5069044650 @default.
• W1967639975 hasAuthorship W1967639975A5070839902 @default.
• W1967639975 hasAuthorship W1967639975A5072378199 @default.
• W1967639975 hasAuthorship W1967639975A5075755839 @default.
• W1967639975 hasAuthorship W1967639975A5076536596 @default.
• W1967639975 hasAuthorship W1967639975A5086964113 @default.
• W1967639975 hasBestOaLocation W19676399751 @default.
• W1967639975 hasConcept C111113717 @default.
• W1967639975 hasConcept C112705442 @default.
• W1967639975 hasConcept C121608353 @default.
• W1967639975 hasConcept C126322002 @default.
• W1967639975 hasConcept C143998085 @default.
• W1967639975 hasConcept C150903083 @default.
• W1967639975 hasConcept C197934379 @default.
• W1967639975 hasConcept C207001950 @default.
• W1967639975 hasConcept C22979827 @default.
• W1967639975 hasConcept C2775934546 @default.
• W1967639975 hasConcept C2778496288 @default.
• W1967639975 hasConcept C2780580376 @default.
• W1967639975 hasConcept C29730261 @default.
• W1967639975 hasConcept C71924100 @default.
• W1967639975 hasConcept C86803240 @default.
• W1967639975 hasConcept C90924648 @default.
• W1967639975 hasConcept C98274493 @default.
• W1967639975 hasConceptScore W1967639975C111113717 @default.
• W1967639975 hasConceptScore W1967639975C112705442 @default.
• W1967639975 hasConceptScore W1967639975C121608353 @default.
• W1967639975 hasConceptScore W1967639975C126322002 @default.

• next